A chiropractor walks through the risks he sees in buying peptides outside approved channels and why physicians won't point patients to a seller.
Recap by typeshit. Full story at Dr. Jones, DC.
Dr. Woo points to the official position of the AAO and NANOS on whether routine eye exams just to check for NAION are needed.
USA TODAY covers the copycat GLP-1 crackdown, from the Apothecary Pharma recall to an import alert on a Chengdu factory. Novo says it has filed over 130 lawsuits.
A fitness coach says clients on GLP-1 drugs often focus on how fast weight drops instead of whether they eat enough protein.
She points to women getting pregnant unexpectedly after GLP-1s restore ovulation, and questions the mixed messages women get about these drugs and fertility.
Spierings explains why the placebo effect makes skincare hard to study, in a clip from the show's full collagen peptides episode.
Hollis talks through the investigational obesity drug and asks what the research could mean beyond the number on the scale.
Loading…